A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Disease Name: 
Hepatocellular Carcinoma, Liver Cancer
Study Status: 
Date: 
March 14, 2024